@ayushmit: Hi Ayush ji, thanks a lot for sharing info and insights from your research on Ideal Cures. In case VT is able to emulate some of what IC has apparently been able to do in terms of margin expansion and consistency, it will be indeed quite an exciting prospect.
@vikasbargale – Hi Vikas ji, financial data above is taken from: (a) ARs of Vikram Thermo; (b) Public filings of Ideal Cures with MCA ( couldn’t find it at no cost, hence paid an online vendor to obtain those). If required, can share the files with you on your email ID etc.
Product data for these is based on info shared by them on their websites, their product brochures uploaded on CPHI sites etc.
| Subscribe To Our Free Newsletter |
